{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:25:11Z","timestamp":1765545911157,"version":"build-2065373602"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2014,3,7]],"date-time":"2014-03-07T00:00:00Z","timestamp":1394150400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"DOI":"10.1007\/s12031-014-0233-7","type":"journal-article","created":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T02:41:03Z","timestamp":1394073663000},"source":"Crossref","is-referenced-by-count":4,"title":["Complexing A\u03b2 Prevents the Cellular Anomalies Induced by the Peptide Alone"],"prefix":"10.1007","author":[{"given":"A. G.","family":"Henriques","sequence":"first","affiliation":[]},{"given":"J. M.","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"B.","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"R.","family":"Ruivo","sequence":"additional","affiliation":[]},{"given":"E. F.","family":"da Cruz e Silva","sequence":"additional","affiliation":[]},{"given":"O. A. B.","family":"da Cruz e Silva","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,3,7]]},"reference":[{"key":"233_CR1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ntt.2003.12.007","volume":"26","author":"FC Amador","year":"2004","unstructured":"Amador FC, Henriques AG, da Cruz e Silva OA, da Cruz e Silva EF (2004) Monitoring protein phosphatase 1 isoform levels as a marker for cellular stress. Neurotoxicol Teratol 26:387\u2013395","journal-title":"Neurotoxicol Teratol"},{"key":"233_CR2","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0196-9781(02)00070-0","volume":"23","author":"CS Atwood","year":"2002","unstructured":"Atwood CS, Martins RN, Smith MA, Perry G (2002) Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins. Peptides 23:1343\u20131350","journal-title":"Peptides"},{"key":"233_CR3","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1161591","volume":"321","author":"DL Brody","year":"2008","unstructured":"Brody DL, Magnoni S, Schwetye KE et al (2008) Amyloid-beta dynamics correlate with neurological status in the injured human brain. Science 321:1221\u20131224","journal-title":"Science"},{"key":"233_CR4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3940(96)13147-5","volume":"218","author":"FC Bronfman","year":"1996","unstructured":"Bronfman FC, Garrido J, Alvarez A, Morgan C, Inestrosa NC (1996) Laminin inhibits amyloid-beta-peptide fibrillation. Neurosci Lett 218:201\u2013203","journal-title":"Neurosci Lett"},{"key":"233_CR5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0197-4580(00)00172-X","volume":"21","author":"CD Carlson","year":"2000","unstructured":"Carlson CD, Czilli DL, Gitter BD (2000) Regulation of amyloid precursor protein processing by Abeta in human glioma cells. Neurobiol Aging 21:747\u2013756","journal-title":"Neurobiol Aging"},{"key":"233_CR6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1517\/14728222.2010.488222","volume":"14","author":"E Carro","year":"2010","unstructured":"Carro E (2010) Gelsolin as therapeutic target in Alzheimer\u2019s disease. Expert Opin Ther Targets 14:585\u2013592","journal-title":"Expert Opin Ther Targets"},{"key":"233_CR7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/bbrc.1999.0623","volume":"258","author":"VP Chauhan","year":"1999","unstructured":"Chauhan VP, Ray I, Chauhan A, Wisniewski HM (1999) Binding of gelsolin, a secretory protein, to amyloid beta-protein. Biochem Biophys Res Commun 258:241\u2013246","journal-title":"Biochem Biophys Res Commun"},{"key":"233_CR8","doi-asserted-by":"crossref","unstructured":"Chauhan V, Ji L, Chauhan A (2008) Anti-amyloidogenic, anti-oxidant and anti-apoptotic role of gelsolin in Alzheimer\u2019s disease. Biogerontology 9:381\u2013389. doi: 10.1007\/s10522-008-9169-z","DOI":"10.1007\/s10522-008-9169-z"},{"key":"233_CR9","doi-asserted-by":"crossref","unstructured":"da Cruz e Silva EF, da Cruz e Silva OA (2003) Protein phosphorylation and APP metabolism. Neurochem Res 28:1553\u20131561","DOI":"10.1023\/A:1025630627319"},{"key":"233_CR10","doi-asserted-by":"crossref","first-page":"32046","DOI":"10.1074\/jbc.M201750200","volume":"277","author":"KN Dahlgren","year":"2002","unstructured":"Dahlgren KN, Manelli AM, Stine WB Jr, Baker LK, Krafft GA, LaDu MJ (2002) Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem 277:32046\u201332053","journal-title":"J Biol Chem"},{"key":"233_CR11","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1471-4159.1995.65020931.x","volume":"65","author":"J Davis-Salinas","year":"1995","unstructured":"Davis-Salinas J, Saporito-Irwin SM, Cotman CW, Van Nostrand WE (1995) Amyloid beta-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J Neurochem 65:931\u2013934","journal-title":"J Neurochem"},{"key":"233_CR12","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1046\/j.1471-4159.1999.0730742.x","volume":"73","author":"B Drouet","year":"1999","unstructured":"Drouet B, Pincon-Raymond M, Chambaz J, Pillot T (1999) Laminin 1 attenuates beta-amyloid peptide Abeta(1\u201340) neurotoxicity of cultured fetal rat cortical neurons. J Neurochem 73:742\u2013749","journal-title":"J Neurochem"},{"key":"233_CR13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0197-4580(94)90125-2","volume":"15","author":"S Gandy","year":"1994","unstructured":"Gandy S, Caporaso G, Buxbaum J, Frangione B, Greengard P (1994) APP processing, a beta-amyloidogenesis, and the pathogenesis of Alzheimer\u2019s disease. Neurobiol Aging 15:253\u2013256","journal-title":"Neurobiol Aging"},{"key":"233_CR14","doi-asserted-by":"crossref","first-page":"10582","DOI":"10.1523\/JNEUROSCI.1736-09.2009","volume":"29","author":"ML Giuffrida","year":"2009","unstructured":"Giuffrida ML, Caraci F, Pignataro B et al (2009) Beta-amyloid monomers are neuroprotective. J Neurosci 29:10582\u201310587","journal-title":"J Neurosci"},{"key":"233_CR15","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW (1984) Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885\u2013890","journal-title":"Biochem Biophys Res Commun"},{"key":"233_CR16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3233\/JAD-2010-100279","volume":"21","author":"A Guntert","year":"2010","unstructured":"Guntert A, Campbell J, Saleem M et al (2010) Plasma gelsolin is decreased and correlates with rate of decline in Alzheimer\u2019s disease. J Alzheimers Dis 21:585\u2013596","journal-title":"J Alzheimers Dis"},{"key":"233_CR17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3233\/JAD-2007-11112","volume":"11","author":"AG Henriques","year":"2007","unstructured":"Henriques AG, Vieira SI, Rebelo S, Domingues SC, da Cruz e Silva EF, da Cruz e Silva OA (2007) Isoform specific amyloid-beta protein precursor metabolism. J Alzheimers Dis 11:85\u201395","journal-title":"J Alzheimers Dis"},{"key":"233_CR18","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/jnr.21959","volume":"87","author":"AG Henriques","year":"2009","unstructured":"Henriques AG, Vieira SI, Crespo-Lopez ME, Guiomar de Oliveira MA, da Cruz e Silva EF, da Cruz e Silva OA (2009a) Intracellular sAPP retention in response to Abeta is mapped to cytoskeleton-associated structures. J Neurosci Res 87:1449\u20131461","journal-title":"J Neurosci Res"},{"key":"233_CR19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12031-009-9192-9","volume":"39","author":"AG Henriques","year":"2009","unstructured":"Henriques AG, Vieira SI, da Cruz e Silva EF (2009b) Abeta hinders nuclear targeting of AICD and Fe65 in primary neuronal cultures. J Mol Neurosci 39:248\u2013255","journal-title":"J Mol Neurosci"},{"key":"233_CR20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1471-4159.2010.06643.x","volume":"113","author":"AG Henriques","year":"2010","unstructured":"Henriques AG, Vieira SI, da Cruz e Silva EF, da Cruz e Silva OA (2010) Abeta promotes Alzheimer\u2019s disease-like cytoskeleton abnormalities with consequences to APP processing in neurons. J Neurochem 113:761\u2013771","journal-title":"J Neurochem"},{"key":"233_CR21","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/sj.mt.6300253","volume":"15","author":"AC Hirko","year":"2007","unstructured":"Hirko AC, Meyer EM, King MA, Hughes JA (2007) Peripheral transgene expression of plasma gelsolin reduces amyloid in transgenic mouse models of Alzheimer\u2019s disease. Mol Ther 15:1623\u20131629","journal-title":"Mol Ther"},{"key":"233_CR22","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1083\/jcb.110.6.1983","volume":"110","author":"T Howard","year":"1990","unstructured":"Howard T, Chaponnier C, Yin H, Stossel T (1990) Gelsolin-actin interaction and actin polymerization in human neutrophils. J Cell Biol 110:1983\u20131991","journal-title":"J Cell Biol"},{"key":"233_CR23","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/bi00335a046","volume":"24","author":"PA Janmey","year":"1985","unstructured":"Janmey PA, Chaponnier C, Lind SE, Zaner KS, Stossel TP, Yin HL (1985) Interactions of gelsolin and gelsolin-actin complexes with actin. Effects of calcium on actin nucleation, filament severing, and end blocking. Biochemistry 24:3714\u20133723","journal-title":"Biochemistry"},{"key":"233_CR24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/WNR.0b013e3282f5f79a","volume":"19","author":"L Ji","year":"2008","unstructured":"Ji L, Chauhan A, Chauhan V (2008) Cytoplasmic gelsolin in pheochromocytoma-12 cells forms a complex with amyloid beta-protein. Neuroreport 19:463\u2013466","journal-title":"Neuroreport"},{"key":"233_CR25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000095267","volume":"3","author":"C Kaether","year":"2006","unstructured":"Kaether C, Haass C, Steiner H (2006) Assembly, trafficking and function of gamma-secretase. Neurodegener Dis 3:275\u2013283","journal-title":"Neurodegener Dis"},{"key":"233_CR26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.expneurol.2009.09.005","volume":"221","author":"YG Kaminsky","year":"2010","unstructured":"Kaminsky YG, Marlatt MW, Smith MA, Kosenko EA (2010) Subcellular and metabolic examination of amyloid-beta peptides in Alzheimer disease pathogenesis: evidence for Abeta(25\u201335). Exp Neurol 221:26\u201337","journal-title":"Exp Neurol"},{"key":"233_CR27","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1468-1331.2008.02133.x","volume":"15","author":"A Kulakowska","year":"2008","unstructured":"Kulakowska A, Drozdowski W, Sadzynski A, Bucki R, Janmey PA (2008) Gelsolin concentration in cerebrospinal fluid from patients with multiple sclerosis and other neurological disorders. Eur J Neurol 15:584\u2013588","journal-title":"Eur J Neurol"},{"key":"233_CR28","doi-asserted-by":"crossref","first-page":"8239","DOI":"10.1016\/S0021-9258(18)68469-8","volume":"263","author":"DJ Kwiatkowski","year":"1988","unstructured":"Kwiatkowski DJ, Mehl R, Izumo S, Nadal-Ginard B, Yin HL (1988) Muscle is the major source of plasma gelsolin. J Biol Chem 263:8239\u20138243","journal-title":"J Biol Chem"},{"key":"233_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1297.001","volume":"1019","author":"HG Lee","year":"2004","unstructured":"Lee HG, Casadesus G, Zhu X, Takeda A, Perry G, Smith MA (2004) Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease. Ann N Y Acad Sci 1019:1\u20134","journal-title":"Ann N Y Acad Sci"},{"key":"233_CR30","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/pro.5560020312","volume":"2","author":"H LeVine 3rd","year":"1993","unstructured":"LeVine H 3rd (1993) Thioflavine T interaction with synthetic Alzheimer\u2019s disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci 2:404\u2013410","journal-title":"Protein Sci"},{"key":"233_CR31","doi-asserted-by":"crossref","first-page":"12243","DOI":"10.1073\/pnas.91.25.12243","volume":"91","author":"A Lorenzo","year":"1994","unstructured":"Lorenzo A, Yankner BA (1994) Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci U S A 91:12243\u201312247","journal-title":"Proc Natl Acad Sci U S A"},{"key":"233_CR32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1523\/JNEUROSCI.23-01-00029.2003","volume":"23","author":"Y Matsuoka","year":"2003","unstructured":"Matsuoka Y, Saito M, LaFrancois J et al (2003) Novel therapeutic approach for the treatment of Alzheimer\u2019s disease by peripheral administration of agents with an affinity to beta-amyloid. J Neurosci 23:29\u201333","journal-title":"J Neurosci"},{"key":"233_CR33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0896-6273(93)90315-I","volume":"10","author":"MP Mattson","year":"1993","unstructured":"Mattson MP, Cheng B, Culwell AR, Esch FS, Lieberburg I, Rydel RE (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron 10:243\u2013254","journal-title":"Neuron"},{"key":"233_CR34","doi-asserted-by":"crossref","first-page":"12683","DOI":"10.1073\/pnas.95.21.12683","volume":"95","author":"H Meziane","year":"1998","unstructured":"Meziane H, Dodart JC, Mathis C et al (1998) Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice. Proc Natl Acad Sci U S A 95:12683\u201312688","journal-title":"Proc Natl Acad Sci U S A"},{"key":"233_CR35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3940(99)00273-6","volume":"266","author":"A Monji","year":"1999","unstructured":"Monji A, Tashiro K, Yoshida I et al (1999) Laminin inhibits both Abeta40 and Abeta42 fibril formation but does not affect Abeta40 or Abeta42-induced cytotoxicity in PC12 cells. Neurosci Lett 266:85\u201388","journal-title":"Neurosci Lett"},{"key":"233_CR36","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1074\/jbc.270.13.7104","volume":"270","author":"U Monning","year":"1995","unstructured":"Monning U, Sandbrink R, Weidemann A, Banati RB, Masters CL, Beyreuther K (1995) Extracellular matrix influences the biogenesis of amyloid precursor protein in microglial cells. J Biol Chem 270:7104\u20137110","journal-title":"J Biol Chem"},{"key":"233_CR37","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/(SICI)1097-4547(19980615)52:6<661::AID-JNR5>3.0.CO;2-6","volume":"52","author":"MT Moreno-Flores","year":"1998","unstructured":"Moreno-Flores MT, Salinero O, Wandosell F (1998) BetaA amyloid peptide (25\u201335) induced APP expression in cultured astrocytes. J Neurosci Res 52:661\u2013671","journal-title":"J Neurosci Res"},{"key":"233_CR38","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1590\/S0100-879X2001000500006","volume":"34","author":"C Morgan","year":"2001","unstructured":"Morgan C, Inestrosa NC (2001) Interactions of laminin with the amyloid beta peptide. Implications for Alzheimer\u2019s disease. Braz J Med Biol Res 34:597\u2013601","journal-title":"Braz J Med Biol Res"},{"key":"233_CR39","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0196-9781(02)00058-X","volume":"23","author":"C Morgan","year":"2002","unstructured":"Morgan C, Bugueno MP, Garrido J, Inestrosa NC (2002) Laminin affects polymerization, depolymerization and neurotoxicity of Abeta peptide. Peptides 23:1229\u20131240","journal-title":"Peptides"},{"key":"233_CR40","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/13506129409148629","volume":"1","author":"T Paunio","year":"1994","unstructured":"Paunio T (1994) Quantification of serum and cerebrospinal fluid gelsolin in familial amyloidosis, Finnish type (AGel). Amyloid 1:80\u201389","journal-title":"Amyloid"},{"key":"233_CR41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/JMN:23:1-2:097","volume":"23","author":"C Pereira","year":"2004","unstructured":"Pereira C, Ferreiro E, Cardoso SM, de Oliveira CR (2004) Cell degeneration induced by amyloid-beta peptides: implications for Alzheimer\u2019s disease. J Mol Neurosci 23:97\u2013104","journal-title":"J Mol Neurosci"},{"key":"233_CR42","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1523\/JNEUROSCI.13-04-01676.1993","volume":"13","author":"CJ Pike","year":"1993","unstructured":"Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW (1993) Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 13:1676\u20131687","journal-title":"J Neurosci"},{"key":"233_CR43","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.neurobiolaging.2004.08.003","volume":"26","author":"H Qiao","year":"2005","unstructured":"Qiao H, Koya RC, Nakagawa K et al (2005) Inhibition of Alzheimer\u2019s amyloid-beta peptide-induced reduction of mitochondrial membrane potential and neurotoxicity by gelsolin. Neurobiol Aging 26:849\u2013855","journal-title":"Neurobiol Aging"},{"key":"233_CR44","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0006-8993(99)02315-X","volume":"853","author":"I Ray","year":"2000","unstructured":"Ray I, Chauhan A, Wegiel J, Chauhan VP (2000) Gelsolin inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils. Brain Res 853:344\u2013351","journal-title":"Brain Res"},{"key":"233_CR45","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1006\/excr.1997.3606","volume":"234","author":"TL Schmitt","year":"1997","unstructured":"Schmitt TL, Steiner E, Trieb K, Grubeck-Loebenstein B (1997) Amyloid beta-protein(25\u201335) increases cellular APP and inhibits the secretion of APPs in human extraneuronal cells. Exp Cell Res 234:336\u2013340","journal-title":"Exp Cell Res"},{"key":"233_CR46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0896-6273(03)00367-2","volume":"39","author":"T Soucek","year":"2003","unstructured":"Soucek T, Cumming R, Dargusch R, Maher P, Schubert D (2003) The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron 39:43\u201356","journal-title":"Neuron"},{"key":"233_CR47","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1523\/JNEUROSCI.14-03-01038.1994","volume":"14","author":"J Tanaka","year":"1994","unstructured":"Tanaka J, Sobue K (1994) Localization and characterization of gelsolin in nervous tissues: gelsolin is specifically enriched in myelin-forming cells. J Neurosci 14:1038\u20131052","journal-title":"J Neurosci"},{"key":"233_CR48","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","volume":"286","author":"R Vassar","year":"1999","unstructured":"Vassar R, Bennett BD, Babu-Khan S et al (1999) Beta-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286:735\u2013741","journal-title":"Science"},{"key":"233_CR49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11010-009-0084-7","volume":"328","author":"SI Vieira","year":"2009","unstructured":"Vieira SI, Rebelo S, Domingues SC, da Cruz e Silva EF, da Cruz e Silva OA (2009) S655 phosphorylation enhances APP secretory traffic. Mol Cell Biochem 328:145\u2013154","journal-title":"Mol Cell Biochem"},{"key":"233_CR50","doi-asserted-by":"crossref","first-page":"36788","DOI":"10.1074\/jbc.M104350200","volume":"276","author":"R Yan","year":"2001","unstructured":"Yan R, Han P, Miao H, Greengard P, Xu H (2001) The transmembrane domain of the Alzheimer\u2019s beta-secretase (BACE1) determines its late Golgi localization and access to beta-amyloid precursor protein (APP) substrate. J Biol Chem 276:36788\u201336796","journal-title":"J Biol Chem"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-014-0233-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-014-0233-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-014-0233-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T19:25:37Z","timestamp":1648495537000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-014-0233-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,7]]},"references-count":50,"alternative-id":["233"],"URL":"https:\/\/doi.org\/10.1007\/s12031-014-0233-7","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"type":"print","value":"0895-8696"},{"type":"electronic","value":"1559-1166"}],"subject":[],"published":{"date-parts":[[2014,3,7]]}}}